$THC
TENET HEALTHCARE CORP Stock $thc

$thc Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000007031822000013 Filed on February 18, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$4.856B	$19.49B	$4.915B
YoY Change	-1.2%	10.46%	2.27%
Cost Of Revenue	$838.0M	$3.328B	$824.0M
YoY Change	1.7%	11.6%	2.62%
Gross Profit	$4.018B	$16.16B	$4.091B
YoY Change	-1.78%	10.23%	2.2%
Gross Profit Margin	82.74%	82.92%	83.23%
Selling, General & Admin	$2.188B	$9.290B	$2.225B
YoY Change	-1.66%	10.36%	-3.97%
% of Gross Profit	54.45%	57.5%	54.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$201.0M	$855.0M	$233.0M
YoY Change	-13.73%	-0.23%	4.48%
% of Gross Profit	5.0%	5.29%	5.7%
Operating Expenses	$3.418B	$13.94B	$3.529B
YoY Change	-3.15%	4.02%	1.35%
Operating Profit	$600.0M	$2.871B	$562.0M
YoY Change	6.76%	44.34%	7.87%
Interest Expense	-$144.0M	$923.0M	-$176.0M
YoY Change	-18.18%	-7.98%	-3.3%
% of Operating Profit	-24.0%	32.15%	-31.32%
Other Income/Expense, Net	-$2.000M	$14.00M	-$2.000M
YoY Change	0.0%	1300.0%	0.0%
Pretax Income	$528.0M	$1.888B	$676.0M
YoY Change	-21.89%	181.37%	214.42%
Income Tax	$108.0M	$411.0M	$130.0M
% Of Pretax Income	20.45%	21.77%	19.23%
Net Earnings	$249.0M	$1.476B	$546.0M
YoY Change	-54.4%	92.19%	340.32%
Net Earnings / Revenue	5.13%	7.58%	11.11%
Basic Earnings Per Share		$8.55	$3.92
Diluted Earnings Per Share	$2.287M	$8.42	$3.86
COMMON SHARES
Basic Shares Outstanding	107.1M shares	106.8M shares	105.5M shares
Diluted Shares Outstanding		108.6M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.364B	$2.364B	$2.446B
YoY Change	-3.35%	-3.35%	833.59%
Cash & Equivalents	$2.364B	$2.364B	$2.446B
Short-Term Investments
Other Short-Term Assets	$1.557B	$1.376B	$1.503B
YoY Change	3.59%	-6.52%	9.79%
Inventory	$384.0M	$384.0M	$368.0M
Prepaid Expenses	$252.0M
Receivables	$2.770B	$2.951B	$2.690B
Other Receivables	$0.00	$0.00	$1.000M
Total Short-Term Assets	$7.075B	$7.075B	$7.147B
YoY Change	-1.01%	-1.01%	40.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.427B	$7.549B	$6.692B
YoY Change	-3.96%	-4.25%	-2.7%
Goodwill	$9.261B		$8.808B
YoY Change	5.14%		21.46%
Intangibles	$1.497B		$1.600B
YoY Change	-6.44%		-0.12%
Long-Term Investments	$1.806B	$1.872B	$1.024B
YoY Change	76.37%	71.12%	4.7%
Other Assets	$65.00M	$112.0M	$325.0M
YoY Change	-80.0%	-69.48%	77.6%
Total Long-Term Assets	$20.50B	$20.50B	$19.96B
YoY Change	2.73%	2.73%	9.16%
TOTAL ASSETS
Total Short-Term Assets	$7.075B	$7.075B	$7.147B
Total Long-Term Assets	$20.50B	$20.50B	$19.96B
Total Assets	$27.58B	$27.58B	$27.11B
YoY Change	1.75%	1.75%	16.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.300B	$1.300B	$1.207B
YoY Change	7.71%	7.71%	0.25%
Accrued Expenses	$1.099B	$1.300B	$1.190B
YoY Change	-7.65%	-5.66%	6.06%
Deferred Revenue	$959.0M		$659.0M
YoY Change	45.52%		980.33%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$135.0M	$135.0M	$145.0M
YoY Change	-6.9%	-6.9%	-15.2%
Total Short-Term Liabilities	$5.109B	$5.109B	$4.847B
YoY Change	5.41%	5.41%	15.27%
LONG-TERM LIABILITIES
Long-Term Debt	$15.51B	$15.51B	$15.57B
YoY Change	-0.4%	-0.4%	6.82%
Other Long-Term Liabilities	$1.439B	$2.666B	$1.617B
YoY Change	-11.01%	-29.23%	15.75%
Total Long-Term Liabilities	$1.439B	$18.18B	$1.617B
YoY Change	-11.01%	-6.02%	15.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.109B	$5.109B	$4.847B
Total Long-Term Liabilities	$1.439B	$18.18B	$1.617B
Total Liabilities	$23.32B	$26.55B	$24.22B
YoY Change	-3.7%	-1.95%	13.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.214B		-$2.128B
YoY Change	-42.95%		-15.32%
Common Stock	$8.000M		$7.000M
YoY Change	14.29%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.028B	$1.028B	$28.00M
YoY Change
Total Liabilities & Shareholders Equity	$27.58B	$27.58B	$27.11B
YoY Change	1.75%	1.75%	16.01%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$249.0M	$1.476B	$546.0M
YoY Change	-54.4%	92.19%	340.32%
Depreciation, Depletion And Amortization	$201.0M	$855.0M	$233.0M
YoY Change	-13.73%	-0.23%	4.48%
Cash From Operating Activities	$357.0M	$1.568B	$446.0M
YoY Change	-19.96%	-53.98%	-14.23%
INVESTING ACTIVITIES
Capital Expenditures	-$304.0M	$658.0M	-$166.0M
YoY Change	83.13%	21.85%	-6.74%
Acquisitions		$1.220B
YoY Change		3.65%
Other Investing Activities	-$1.212B	$7.000M	-$1.036B
YoY Change	16.99%	-141.18%	6806.67%
Cash From Investing Activities	-$1.516B	-$714.0M	-$1.202B
YoY Change	26.12%	-55.6%	522.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.231B	-$936.0M	-98.00M
YoY Change	-1356.12%	-343.12%	-74.14%
NET CHANGE
Cash From Operating Activities	357.0M	$1.568B	446.0M
Cash From Investing Activities	-1.516B	-$714.0M	-1.202B
Cash From Financing Activities	1.231B	-$936.0M	-98.00M
Net Change In Cash	72.00M	-$82.00M	-854.0M
YoY Change	-108.43%	-103.75%	1542.31%
FREE CASH FLOW
Cash From Operating Activities	$357.0M	$1.568B	$446.0M
Capital Expenditures	-$304.0M	$658.0M	-$166.0M
Free Cash Flow	$661.0M	$910.0M	$612.0M
YoY Change	8.01%	-68.26%	-12.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000070318
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermInvestmentsAndReceivablesNet
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermInvestmentsAndReceivablesNet
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75254
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	1-7293
CY2021	dei	Entity Registrant Name EntityRegistrantName	TENET HEALTHCARE CORP
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-2557091
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	14201 Dallas Parkway
CY2021	dei	City Area Code CityAreaCode	469
CY2021	dei	Local Phone Number LocalPhoneNumber	893-2200
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	5400000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107416704	shares
CY2021	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2021	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2364000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2446000000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2770000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2690000000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	384000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	368000000	USD
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	140000000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1557000000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1503000000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7075000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	7147000000	USD
CY2021Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	3254000000	USD
CY2020Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2534000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	65000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	325000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5960000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	6043000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6427000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6692000000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	9261000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	8808000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1374000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1284000000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1497000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1600000000	USD
CY2021Q4	us-gaap	Assets Assets	27579000000	USD
CY2020Q4	us-gaap	Assets Assets	27106000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	135000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	145000000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1300000000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1207000000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	896000000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	942000000	USD
CY2021Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	254000000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	243000000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	203000000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	248000000	USD
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	70000000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	959000000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	659000000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1362000000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1333000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5109000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4847000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15511000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15574000000	USD
CY2021Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	791000000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	735000000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	421000000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	497000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	36000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	29000000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15000000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	918000000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1439000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1617000000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	23322000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	24217000000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2203000000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1952000000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155520691	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	154407524	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	8000000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	7000000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4877000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4844000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-233000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-281000000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1214000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2128000000	USD
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48331649	shares
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48337947	shares
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2410000000	USD
CY2020Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2414000000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1028000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	28000000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1026000000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	909000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2054000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	937000000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27579000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27106000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19485000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17640000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18479000000	USD
CY2021	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	191000000	USD
CY2020	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	882000000	USD
CY2019	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	0	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	218000000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	169000000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	175000000	USD
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8878000000	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8418000000	USD
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8698000000	USD
CY2021	us-gaap	Supplies Expense SuppliesExpense	3328000000	USD
CY2020	us-gaap	Supplies Expense SuppliesExpense	2982000000	USD
CY2019	us-gaap	Supplies Expense SuppliesExpense	3057000000	USD
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	4206000000	USD
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	4125000000	USD
CY2019	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	4171000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	855000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	857000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	850000000	USD
CY2021	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	85000000	USD
CY2020	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	290000000	USD
CY2019	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	185000000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-116000000	USD
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-44000000	USD
CY2019	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-141000000	USD
CY2021	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	445000000	USD
CY2020	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	14000000	USD
CY2019	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	-15000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	2871000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	1989000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	1537000000	USD
CY2021	us-gaap	Interest Expense InterestExpense	923000000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1003000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	985000000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-316000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-227000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1888000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	671000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	320000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	411000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-97000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	160000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1477000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	768000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	160000000	USD
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-1000000	USD
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	USD
CY2019	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	15000000	USD
CY2021	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2020	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2019	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	4000000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1000000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	11000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	1476000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	768000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	171000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	562000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	369000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	386000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	914000000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	399000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-215000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	915000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	399000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-226000000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1000000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	11000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	914000000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	399000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-215000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	8.56
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.80
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.19
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.11
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	8.55
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.80
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.08
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	8.43
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.75
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.19
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.11
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.42
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.75
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.08
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106833000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105010000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103398000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108571000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106263000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103398000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	1476000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	768000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	171000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-50000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	41000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	52000000	USD
CY2021	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	11000000	USD
CY2020	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	9000000	USD
CY2019	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	10000000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1000000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	1000000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	0	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	62000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-31000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-42000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	14000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-7000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-8000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	48000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-24000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1524000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	744000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	137000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	562000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	369000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	386000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	962000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	375000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-249000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	624000000	USD
CY2019	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-21000000	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	162000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34000000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	18000000	USD
CY2019	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	9000000	USD
CY2019	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	38000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	437000000	USD
CY2020	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	582000000	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	152000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-24000000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	4000000	USD
CY2020	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	51000000	USD
CY2020	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	61000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	937000000	USD
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	1140000000	USD
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	206000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	48000000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	11000000	USD
CY2021	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	97000000	USD
CY2021	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	49000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2054000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	1476000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	768000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	171000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	855000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	857000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	850000000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	250000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-128000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	144000000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	56000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	44000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	42000000	USD
CY2021	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	85000000	USD
CY2020	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	290000000	USD
CY2019	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	185000000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-116000000	USD
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-44000000	USD
CY2019	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-141000000	USD
CY2021	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	445000000	USD
CY2020	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	14000000	USD
CY2019	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	-15000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-316000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-227000000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	10000000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	37000000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	32000000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	33000000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	38000000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	35000000	USD
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-1000000	USD
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	0	USD
CY2019	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	15000000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	33000000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	29000000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	15000000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	197000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-195000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	247000000	USD
CY2021	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	52000000	USD
CY2020	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	145000000	USD
CY2019	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	94000000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-68000000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-19000000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-8000000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-584000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1302000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12000000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	28000000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	221000000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3000000	USD
CY2021	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	153000000	USD
CY2020	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	333000000	USD
CY2019	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	192000000	USD
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	USD
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1000000	USD
CY2019	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1568000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3407000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1233000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	658000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	540000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	670000000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1220000000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1177000000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	25000000	USD
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1248000000	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	77000000	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	63000000	USD
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2020	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2019	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	17000000	USD
CY2021	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	31000000	USD
CY2020	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	59000000	USD
CY2019	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	82000000	USD
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	108000000	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	44000000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	62000000	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7000000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-17000000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	24000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-714000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1608000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-619000000	USD
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	740000000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2640000000	USD
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	740000000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	2640000000	USD
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3221000000	USD
CY2020	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3293000000	USD
CY2019	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	6131000000	USD
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2872000000	USD
CY2020	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	3818000000	USD
CY2019	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	5719000000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	31000000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	48000000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	70000000	USD
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	423000000	USD
CY2020	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	287000000	USD
CY2019	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	307000000	USD
CY2021	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	25000000	USD
CY2020	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	14000000	USD
CY2019	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	21000000	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	27000000	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	39000000	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	11000000	USD
CY2021	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	-67000000	USD
CY2020	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	187000000	USD
CY2019	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	0	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-64000000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	33000000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	16000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-936000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	385000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-763000000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-82000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2184000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-149000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2446000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	262000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2364000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2446000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	262000000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	937000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	962000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	946000000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	92000000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12000000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12000000	USD
CY2021	thc	Number Of Hospitals Operated By Subsidiaries NumberOfHospitalsOperatedBySubsidiaries	60	hospital
CY2021	thc	Number Of Healthcare Facilities Operated By Subsidiaries NumberOfHealthcareFacilitiesOperatedBySubsidiaries	535	healthcare_facility
CY2021	thc	Number Of Outpatient Centers Recorded Using Equity Method NumberOfOutpatientCentersRecordedUsingEquityMethod	167	healthcare_facility
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior‑year amounts have been reclassified to conform to the current year presentation. In our consolidated balance sheets, income tax receivable has been reclassified to other current assets, as it is no longer significant enough to present separately. In our consolidated statements of cash flows, long‑term assets has been combined with other items, net, as it is no longer significant enough to present separately, but it remains located within cash flows from investing activities. In addition, within the financing section of our statement of cash flows, proceeds from shares issued under stock</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">‑</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based compensation plans, net of taxes paid related to net share settlement has been combined with other items, net.</span>
CY2021	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in our Consolidated Financial Statements and these accompanying notes. We regularly evaluate the accounting policies and estimates we use. In general, we base the estimates on historical experience and on assumptions that we believe to be reasonable given the particular circumstances in which we operate. Although we believe all adjustments considered necessary for a fair presentation have been included, actual results may vary from those estimates. Financial and statistical information we report to other regulatory agencies may be prepared on a basis other than GAAP or using different assumptions or reporting periods and, therefore, may vary from amounts presented herein. Although we make every effort to ensure that the information we report to those agencies is accurate, complete and consistent with applicable reporting guidelines, we cannot be responsible for the accuracy of the information they make available to the public.
CY2021	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	215000000	USD
CY2020	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	974000000	USD
CY2021	thc	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	178000000	USD
CY2020	thc	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	900000000	USD
CY2019	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	0	USD
CY2021	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	191000000	USD
CY2020	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	882000000	USD
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	5000000	USD
CY2020Q4	us-gaap	Deferred Revenue DeferredRevenue	18000000	USD
CY2021	thc	Cost Report Filing Period After End Of Annual Cost Reporting Period CostReportFilingPeriodAfterEndOfAnnualCostReportingPeriod	P5M
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2364000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2446000000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	95000000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	93000000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	136000000	USD
CY2021	thc	Percentage Investee Results Reflected PercentageInvesteeResultsReflected	1
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	218000000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	169000000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	175000000	USD
CY2021Q4	thc	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	1	renewal_option
CY2021	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2021Q4	thc	Percentage Of Net Operating Revenues Generated By General Hospitals PercentageOfNetOperatingRevenuesGeneratedByGeneralHospitals	0.80
CY2019Q4	thc	Percentage Of Net Operating Revenues Generated By General Hospitals PercentageOfNetOperatingRevenuesGeneratedByGeneralHospitals	0.81
CY2020Q4	thc	Percentage Of Net Operating Revenues Generated By General Hospitals PercentageOfNetOperatingRevenuesGeneratedByGeneralHospitals	0.81
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2770000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2690000000	USD
CY2021	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	747000000	USD
CY2020	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	764000000	USD
CY2019	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	820000000	USD
CY2020Q4	thc	Contract With Customer Asset Percentage To Be Reclassified To Receivable Within90 Days ContractWithCustomerAssetPercentageToBeReclassifiedToReceivableWithin90Days	0.91
CY2021Q4	thc	Contract With Customer Asset Percentage To Be Reclassified To Receivable Within90 Days ContractWithCustomerAssetPercentageToBeReclassifiedToReceivableWithin90Days	0.91
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4000000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4000000	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	5000000	USD
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	23000000	USD
CY2019	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	185000000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	24000000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	85000000	USD
CY2021	us-gaap	Restructuring Costs RestructuringCosts	57000000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8000000	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	20000000	USD
CY2020	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	290000000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	92000000	USD
CY2020	us-gaap	Restructuring Costs RestructuringCosts	184000000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	14000000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	76000000	USD
CY2020	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	16000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	188000000	USD
CY2020	thc	Business Combination Acquisition Related Transaction Costs BusinessCombinationAcquisitionRelatedTransactionCosts	14000000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	42000000	USD
CY2019	us-gaap	Restructuring Costs RestructuringCosts	137000000	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6000000	USD
CY2019	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	16000000	USD
CY2019	thc	Business Combination Acquisition Related Transaction Costs BusinessCombinationAcquisitionRelatedTransactionCosts	6000000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1002000000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1062000000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	333000000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	345000000	USD
CY2021Q4	thc	Lease Right Of Use Asset LeaseRightOfUseAsset	1335000000	USD
CY2020Q4	thc	Lease Right Of Use Asset LeaseRightOfUseAsset	1407000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	201000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	924000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	999000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1125000000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1187000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	106000000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	122000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	176000000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	151000000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	282000000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	273000000	USD
CY2021Q4	thc	Lease Liability LeaseLiability	1407000000	USD
CY2020Q4	thc	Lease Liability LeaseLiability	1460000000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	241000000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	247000000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	211000000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	71000000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	86000000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	85000000	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	9000000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	11000000	USD
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	15000000	USD
CY2021	thc	Finance Lease Cost FinanceLeaseCost	80000000	USD
CY2020	thc	Finance Lease Cost FinanceLeaseCost	97000000	USD
CY2019	thc	Finance Lease Cost FinanceLeaseCost	100000000	USD
CY2021	thc	Variable And Shortterm Lease Costs VariableAndShorttermLeaseCosts	171000000	USD
CY2020	thc	Variable And Shortterm Lease Costs VariableAndShorttermLeaseCosts	156000000	USD
CY2019	thc	Variable And Shortterm Lease Costs VariableAndShorttermLeaseCosts	133000000	USD
CY2021	us-gaap	Lease Cost LeaseCost	492000000	USD
CY2020	us-gaap	Lease Cost LeaseCost	500000000	USD
CY2019	us-gaap	Lease Cost LeaseCost	444000000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10M24D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M18D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2019Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.051
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.054
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.056
CY2019Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.055
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	237000000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	239000000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	197000000	USD
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	12000000	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	15000000	USD
CY2019	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	18000000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	140000000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	154000000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	151000000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	176000000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	304000000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	249000000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	136000000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	98000000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	141000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	236000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	116000000	USD
CY2021Q4	thc	Lessee Lease Liability Payments Next Twelve Months LesseeLeaseLiabilityPaymentsNextTwelveMonths	352000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	211000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	76000000	USD
CY2021Q4	thc	Lessee Lease Liability Payments Due Year Two LesseeLeaseLiabilityPaymentsDueYearTwo	287000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	185000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	48000000	USD
CY2021Q4	thc	Lessee Lease Liability Payments Due Year Three LesseeLeaseLiabilityPaymentsDueYearThree	233000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	156000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	16000000	USD
CY2021Q4	thc	Lessee Lease Liability Payments Due Year Four LesseeLeaseLiabilityPaymentsDueYearFour	172000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	124000000	USD
CY2021Q4	thc	Lease Liability Current LeaseLiabilityCurrent	307000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	11000000	USD
CY2021Q4	thc	Lessee Lease Liability Payments Due Year Five LesseeLeaseLiabilityPaymentsDueYearFive	135000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	456000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	83000000	USD
CY2021Q4	thc	Lessee Lease Liability Payments Due After Year Five LesseeLeaseLiabilityPaymentsDueAfterYearFive	539000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1368000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	350000000	USD
CY2021Q4	thc	Lease Liability Payments Due LeaseLiabilityPaymentsDue	1718000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	243000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	68000000	USD
CY2021Q4	thc	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	311000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1125000000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	282000000	USD
CY2021Q4	thc	Lease Liability LeaseLiability	1407000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	201000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	106000000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	176000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	924000000	USD
CY2021Q4	thc	Lease Liability Noncurrent LeaseLiabilityNoncurrent	1100000000	USD
CY2021Q4	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	443000000	USD
CY2020Q4	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	403000000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	151000000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	176000000	USD
CY2021Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	15646000000	USD
CY2020Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	15719000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	135000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	145000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15511000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15574000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	15797000000	USD
CY2021Q4	thc	Long Term Debt And Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	135000000	USD
CY2021Q4	thc	Long Term Debt And Lease Obligations Repayments Of Principal In Year Two LongTermDebtAndLeaseObligationsRepaymentsOfPrincipalInYearTwo	1983000000	USD
CY2021Q4	thc	Long Term Debt And Lease Obligations Repayments Of Principal In Year Three LongTermDebtAndLeaseObligationsRepaymentsOfPrincipalInYearThree	1446000000	USD
CY2021Q4	thc	Long Term Debt And Lease Obligations Repayments Of Principal In Year Four LongTermDebtAndLeaseObligationsRepaymentsOfPrincipalInYearFour	742000000	USD
CY2021Q4	thc	Long Term Debt And Lease Obligations Repayments Of Principal In Year Five LongTermDebtAndLeaseObligationsRepaymentsOfPrincipalInYearFive	2120000000	USD
CY2021Q4	thc	Long Term Debt And Lease Obligations Repayments Of Principal After Year Five LongTermDebtAndLeaseObligationsRepaymentsOfPrincipalAfterYearFive	9371000000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42000000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	thc	Defined Contribution Plan Number Of Plans Employees Can Participate In DefinedContributionPlanNumberOfPlansEmployeesCanParticipateIn	1	plan
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	98000000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	119000000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	127000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1429000000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1369000000	USD
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	36000000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	47000000	USD
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-42000000	USD
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	92000000	USD
CY2021	thc	Defined Benefit Plan Benefits Paid Or Employer Contribution DefinedBenefitPlanBenefitsPaidOrEmployerContribution	110000000	USD
CY2020	thc	Defined Benefit Plan Benefits Paid Or Employer Contribution DefinedBenefitPlanBenefitsPaidOrEmployerContribution	79000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1313000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1429000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	869000000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	790000000	USD
CY2021	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	62000000	USD
CY2020	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	98000000	USD
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	22000000	USD
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	38000000	USD
CY2021	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	86000000	USD
CY2020	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	57000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	867000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	869000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-446000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-560000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	1311000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	1426000000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	25000000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	63000000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	421000000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	497000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax	294000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax	355000000	USD
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	36000000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	47000000	USD
CY2019	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	58000000	USD
CY2021	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	53000000	USD
CY2020	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	48000000	USD
CY2019	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	46000000	USD
CY2021	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-11000000	USD
CY2020	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-9000000	USD
CY2019	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-10000000	USD
CY2021	thc	Defined Benefit Plan Special Termination Benefit Costs DefinedBenefitPlanSpecialTerminationBenefitCosts	0	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	0	USD
CY2020	thc	Defined Benefit Plan Special Termination Benefit Costs DefinedBenefitPlanSpecialTerminationBenefitCosts	0	USD
CY2019	thc	Defined Benefit Plan Special Termination Benefit Costs DefinedBenefitPlanSpecialTerminationBenefitCosts	1000000	USD
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-6000000	USD
CY2020	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	8000000	USD
CY2019	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	23000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax	61000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax	-32000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax	-42000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax	50000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax	-41000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax	-52000000	USD
CY2021	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-11000000	USD
CY2020	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-9000000	USD
CY2019	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-10000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax	-294000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax	-355000000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax	-323000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	0	USD
CY2019Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	1000000	USD
CY2021Q4	thc	Defined Benefit Plan Expected Future Benefit Payments DefinedBenefitPlanExpectedFutureBenefitPayments	828000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	83000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	84000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	85000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	85000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	85000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	406000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-446000000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	25000000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	421000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	25000000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	479000000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	512000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	12387000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	12735000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5960000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	6043000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6427000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6692000000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2871000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1374000000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1497000000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2884000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1284000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1600000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	786000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	147000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	119000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	108000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	94000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	73000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	245000000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	188000000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	172000000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	188000000	USD
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	9000000	USD
CY2020Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	3000000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1806000000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1024000000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	1815000000	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	1027000000	USD
CY2021Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	47000000	USD
CY2020Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	42000000	USD
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	57000000	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	67000000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	213000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	206000000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1002000000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1062000000	USD
CY2021Q4	thc	Land Heldfor Expansion Other Long Term Receivablesand Other Assets Noncurrent LandHeldforExpansionOtherLongTermReceivablesandOtherAssetsNoncurrent	120000000	USD
CY2020Q4	thc	Land Heldfor Expansion Other Long Term Receivablesand Other Assets Noncurrent LandHeldforExpansionOtherLongTermReceivablesandOtherAssetsNoncurrent	130000000	USD
CY2021Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	3254000000	USD
CY2020Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2534000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax	14000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax	-7000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19485000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17640000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18479000000	USD
CY2021	thc	Malpractice Loss Contingency Adverse Developments In Prior Years MalpracticeLossContingencyAdverseDevelopmentsInPriorYears	131000000	USD
CY2020	thc	Malpractice Loss Contingency Adverse Developments In Prior Years MalpracticeLossContingencyAdverseDevelopmentsInPriorYears	120000000	USD
CY2019	thc	Malpractice Loss Contingency Adverse Developments In Prior Years MalpracticeLossContingencyAdverseDevelopmentsInPriorYears	155000000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	2203000000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	1952000000	USD
CY2021	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	336000000	USD
CY2020	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	186000000	USD
CY2019	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	192000000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	50000000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-6000000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	111000000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	30000000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	26000000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	161000000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	30000000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20000000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	267000000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-131000000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	140000000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-17000000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4000000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	250000000	USD
CY2020	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-127000000	USD
CY2019	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	140000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	411000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-97000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	160000000	USD
CY2021	thc	Valuation Allowance Deferred Tax Asset Change In Amount Attributable To Expiration Or Worthlessness Of Unutilized State Net Operating Loss Carryovers ValuationAllowanceDeferredTaxAssetChangeInAmountAttributableToExpirationOrWorthlessnessOfUnutilizedStateNetOperatingLossCarryovers	-2000000	USD
CY2021	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-2000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-13000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-6000000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	396000000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	141000000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	67000000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	77000000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	33000000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	21000000	USD
CY2021	thc	Income Tax Reconciliation State Net Operating Losses Expired Net Of Federal Income Tax Benefit IncomeTaxReconciliationStateNetOperatingLossesExpiredNetOfFederalIncomeTaxBenefit	0	USD
CY2020	thc	Income Tax Reconciliation State Net Operating Losses Expired Net Of Federal Income Tax Benefit IncomeTaxReconciliationStateNetOperatingLossesExpiredNetOfFederalIncomeTaxBenefit	1000000	USD
CY2019	thc	Income Tax Reconciliation State Net Operating Losses Expired Net Of Federal Income Tax Benefit IncomeTaxReconciliationStateNetOperatingLossesExpiredNetOfFederalIncomeTaxBenefit	2000000	USD
CY2021	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	114000000	USD
CY2020	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	75000000	USD
CY2019	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	79000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	35000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4000000	USD
CY2021	thc	Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationAmount	8000000	USD
CY2020	thc	Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationAmount	6000000	USD
CY2019	thc	Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationAmount	6000000	USD
CY2021	thc	Income Tax Reconciliation Nondeductible Expense Litigation IncomeTaxReconciliationNondeductibleExpenseLitigation	1000000	USD
CY2020	thc	Income Tax Reconciliation Nondeductible Expense Litigation IncomeTaxReconciliationNondeductibleExpenseLitigation	0	USD
CY2019	thc	Income Tax Reconciliation Nondeductible Expense Litigation IncomeTaxReconciliationNondeductibleExpenseLitigation	7000000	USD
CY2021	thc	Effective Income Tax Rate Reconciliation Nondeductible Expense Expired Charitable Contributions Carryforward Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExpiredCharitableContributionsCarryforwardAmount	0	USD
CY2020	thc	Effective Income Tax Rate Reconciliation Nondeductible Expense Expired Charitable Contributions Carryforward Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExpiredCharitableContributionsCarryforwardAmount	-1000000	USD
CY2019	thc	Effective Income Tax Rate Reconciliation Nondeductible Expense Expired Charitable Contributions Carryforward Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExpiredCharitableContributionsCarryforwardAmount	-8000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-5000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2000000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4000000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2000000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-226000000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	133000000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-14000000	USD
CY2021	thc	Income Tax Reconciliation Prior Year Income Taxes And Change In Deferred Taxes IncomeTaxReconciliationPriorYearIncomeTaxesAndChangeInDeferredTaxes	-8000000	USD
CY2020	thc	Income Tax Reconciliation Prior Year Income Taxes And Change In Deferred Taxes IncomeTaxReconciliationPriorYearIncomeTaxesAndChangeInDeferredTaxes	-14000000	USD
CY2019	thc	Income Tax Reconciliation Prior Year Income Taxes And Change In Deferred Taxes IncomeTaxReconciliationPriorYearIncomeTaxesAndChangeInDeferredTaxes	3000000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3000000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	10000000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	411000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-97000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	160000000	USD
CY2020	thc	Income Tax Expense Benefit Cares Act IncomeTaxExpenseBenefitCARESAct	-88000000	USD
CY2020	thc	Valuation Allowance Deferred Tax Asset Change In Amount Attributable To Change In Tax Accounting Method ValuationAllowanceDeferredTaxAssetChangeInAmountAttributableToChangeInTaxAccountingMethod	-126000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	532000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	621000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges	2000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges	8000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	215000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	173000000	USD
CY2021Q4	thc	Deferred Tax Assets Medicare Advance Payments DeferredTaxAssetsMedicareAdvancePayments	209000000	USD
CY2020Q4	thc	Deferred Tax Assets Medicare Advance Payments DeferredTaxAssetsMedicareAdvancePayments	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	234000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	223000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	396000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	385000000	USD
CY2021Q4	thc	Deferred Tax Assets Other Long Term Liabilities DeferredTaxAssetsOtherLongTermLiabilities	23000000	USD
CY2020Q4	thc	Deferred Tax Assets Other Long Term Liabilities DeferredTaxAssetsOtherLongTermLiabilities	55000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	242000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	265000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	56000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	74000000	USD
CY2021Q4	thc	Deferred Tax Liabilities Investments And Other Assets DeferredTaxLiabilitiesInvestmentsAndOtherAssets	92000000	USD
CY2020Q4	thc	Deferred Tax Liabilities Investments And Other Assets DeferredTaxLiabilitiesInvestmentsAndOtherAssets	73000000	USD
CY2021Q4	thc	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	10000000	USD
CY2020Q4	thc	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	8000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	99000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	566000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	11000000	USD
CY2021Q4	thc	Deferred Tax Assets Right Of Use Lease Assets And Obligations DeferredTaxAssetsRightOfUseLeaseAssetsAndObligations	208000000	USD
CY2021Q4	thc	Deferred Tax Liabilities Right Of Use Lease Liability And Obligations DeferredTaxLiabilitiesRightOfUseLeaseLiabilityAndObligations	208000000	USD
CY2020Q4	thc	Deferred Tax Assets Right Of Use Lease Assets And Obligations DeferredTaxAssetsRightOfUseLeaseAssetsAndObligations	224000000	USD
CY2020Q4	thc	Deferred Tax Liabilities Right Of Use Lease Liability And Obligations DeferredTaxLiabilitiesRightOfUseLeaseLiabilityAndObligations	224000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	48000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	44000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	86000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	39000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1358000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1272000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1693000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1342000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	57000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1301000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1272000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1638000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1342000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	65000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	325000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	36000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	29000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	29000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	296000000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2000000	USD
CY2021	thc	Valuation Allowance Deferred Tax Asset Increase Decrease Amount Due To Interest Expense Limitations ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAmountDueToInterestExpenseLimitations	2000000	USD
CY2021	thc	Valuation Allowance Deferred Tax Asset Change In Amount Attributable To Expiration Or Worthlessness Of Unutilized State Net Operating Loss Carryovers ValuationAllowanceDeferredTaxAssetChangeInAmountAttributableToExpirationOrWorthlessnessOfUnutilizedStateNetOperatingLossCarryovers	-2000000	USD
CY2021	thc	Valuation Allowance Deferred Tax Asset Change In Amount Attributable To Changes In Expected Realizability Of Deferred Tax Assets ValuationAllowanceDeferredTaxAssetChangeInAmountAttributableToChangesInExpectedRealizabilityOfDeferredTaxAssets	2000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	57000000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-226000000	USD
CY2020	thc	Valuation Allowance Deferred Tax Asset Increase Decrease Amount Due To Interest Expense Limitations ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAmountDueToInterestExpenseLimitations	-211000000	USD
CY2020	thc	Valuation Allowance Deferred Tax Asset Change In Amount Attributable To Expiration Or Worthlessness Of Unutilized State Net Operating Loss Carryovers ValuationAllowanceDeferredTaxAssetChangeInAmountAttributableToExpirationOrWorthlessnessOfUnutilizedStateNetOperatingLossCarryovers	-1000000	USD
CY2020	thc	Valuation Allowance Deferred Tax Asset Change In Amount Attributable To Changes In Expected Realizability Of Deferred Tax Assets ValuationAllowanceDeferredTaxAssetChangeInAmountAttributableToChangesInExpectedRealizabilityOfDeferredTaxAssets	-14000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55000000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	133000000	USD
CY2019	thc	Valuation Allowance Deferred Tax Asset Increase Decrease Amount Due To Interest Expense Limitations ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAmountDueToInterestExpenseLimitations	130000000	USD
CY2019	thc	Valuation Allowance Deferred Tax Asset Change In Amount Attributable To Expiration Or Worthlessness Of Unutilized State Net Operating Loss Carryovers ValuationAllowanceDeferredTaxAssetChangeInAmountAttributableToExpirationOrWorthlessnessOfUnutilizedStateNetOperatingLossCarryovers	-2000000	USD
CY2019	thc	Valuation Allowance Deferred Tax Asset Change In Amount Attributable To Changes In Expected Realizability Of Deferred Tax Assets ValuationAllowanceDeferredTaxAssetChangeInAmountAttributableToChangesInExpectedRealizabilityOfDeferredTaxAssets	5000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	281000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	34000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	32000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	31000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	29000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	31000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	29000000	USD
CY2019	thc	Income Tax Expense Benefit Due To Increase Decrease In Liabilities For Uncertain Tax Positions IncomeTaxExpenseBenefitDueToIncreaseDecreaseInLiabilitiesForUncertainTaxPositions	-11000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	90000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	915000000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106833000	shares
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	8.56
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1738000	shares
CY2021	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	-0.13
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	915000000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108571000	shares
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	8.43
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	399000000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105010000	shares
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.80
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1253000	shares
CY2020	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	-0.05
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	399000000	USD
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106263000	shares
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.75
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-226000000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103398000	shares
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.19
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	0
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-226000000	USD
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103398000	shares
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.19
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	76000000	USD
CY2021Q4	us-gaap	Assets Assets	27579000000	USD
CY2020Q4	us-gaap	Assets Assets	27106000000	USD
CY2019Q4	us-gaap	Assets Assets	23365000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	658000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	540000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	670000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19485000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17640000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18479000000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	218000000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	169000000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	175000000	USD
CY2021	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	3483000000	USD
CY2020	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	3146000000	USD
CY2019	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	2730000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	855000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	857000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	850000000	USD
CY2021	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	3483000000	USD
CY2020	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	3146000000	USD
CY2019	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	2730000000	USD
CY2021	thc	Income Loss From Divested And Closed Businesses IncomeLossFromDivestedAndClosedBusinesses	-1000000	USD
CY2020	thc	Income Loss From Divested And Closed Businesses IncomeLossFromDivestedAndClosedBusinesses	20000000	USD
CY2019	thc	Income Loss From Divested And Closed Businesses IncomeLossFromDivestedAndClosedBusinesses	-2000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	855000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	857000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	850000000	USD
CY2021	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	85000000	USD
CY2020	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	290000000	USD
CY2019	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	185000000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-116000000	USD
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-44000000	USD
CY2019	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-141000000	USD
CY2021	us-gaap	Interest Expense InterestExpense	923000000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1003000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	985000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-316000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-227000000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000000	USD
CY2021	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	445000000	USD
CY2020	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	14000000	USD
CY2019	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	-15000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1888000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	671000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	320000000	USD
CY2021	dei	Auditor Firm AuditorFirmId	34

Files In Submission

Name	View Source	Status
0000070318-22-000013-index-headers.html	Edgar Link	pending
0000070318-22-000013-index.html	Edgar Link	pending
0000070318-22-000013.txt	Edgar Link	pending
0000070318-22-000013-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thc-20211231.htm	Edgar Link	pending
thc-20211231.xsd	Edgar Link	pending
thc-20211231ex10kk.htm	Edgar Link	pending
thc-20211231ex10ll.htm	Edgar Link	pending
thc-20211231ex10mm.htm	Edgar Link	pending
thc-20211231ex10nn.htm	Edgar Link	pending
thc-20211231ex10oo.htm	Edgar Link	pending
thc-20211231ex10qq.htm	Edgar Link	pending
thc-20211231ex10u.htm	Edgar Link	pending
thc-20211231ex10w.htm	Edgar Link	pending
thc-20211231ex10y.htm	Edgar Link	pending
thc-20211231ex21.htm	Edgar Link	pending
thc-20211231ex23.htm	Edgar Link	pending
thc-20211231ex31a.htm	Edgar Link	pending
thc-20211231ex31b.htm	Edgar Link	pending
thc-20211231ex32.htm	Edgar Link	pending
thc-20211231ex4a.htm	Edgar Link	pending
thc-20211231_cal.xml	Edgar Link	unprocessable
thc-20211231_def.xml	Edgar Link	unprocessable
thc-20211231_g1.jpg	Edgar Link	pending
thc-20211231_htm.xml	Edgar Link	completed
thc-20211231_lab.xml	Edgar Link	unprocessable
thc-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THC
TENET HEALTHCARE CORP Stock $thc

2021 Q4 Form 10-K Financial Statement

#000007031822000013 Filed on February 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC TENET HEALTHCARE CORP Stock $thc

2021 Q4 Form 10-K Financial Statement

#000007031822000013 Filed on February 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC
TENET HEALTHCARE CORP Stock $thc